Therapix to Conduct Phase II Clinical Trial for THC compound to Treat Tourette Syndrome
Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess the Effect of TXH-TS01 in Patients with Tourette Syndrome TEL AVIV, Israel, May...